Presentations
4 June, 2013
4 JUNE CONFERENCE SPEAKERS PROGRAMME
Introduction
Dr Nathalie Strub-Wourgaft, Medical Director, Drugs for Neglected Diseases initiative
IEC and NRS Successful Collaboration in Approving Medical Device Clinical Trials: A Product Development Partnership Perspective
Dr Annalene Nel, Medical Director, International Partnership for Microbicides – IPM
Joint Ethics: International Workshop
Dr Samba Cor Sarr, Research Manager, Ministry of Health, Senegal
WHO Pre-Qualification Programme: Facilitating Regional Approval and Patient Access to Treatments
Hiiti B. Sillo, Director General, Tanzania Food & Drugs Authority – TFDA
Article 58: Collaboration Between the European Medicines Agency
Marie-Helene Pinheiro, Principal Regulatory Advisor, European Medicines Agency (EMA)
Are Current Biological Norms Adapted for Clinical Research in Africa?
Dr Bernhards Ogutu, Senior Clinical Trialist (INDEPTH Network), KEMRI
Priority Areas To Be Addressed in Ethics and Regulatory Reviews in Africa
Dr Michael Makanga, Director South-South Cooperation and Head of Africa Office, EDCTP
Capacity Strengthening Initiatives for Regulatory Authorities in Africa
Esnart Mwape, Director, Pharmaceutical Regulatory Authority, Zambia
Can We Define Essential Technical Standards for Dossiers Necessary for Regulatory Harmonization?
Dr Samvel Azatyan, Manager, Medicines Regulatory Support Programme, World Health Organization (WHO)
Meeting Report: The Road to Regulatory Harmonization for Africa
Strengthening Research Governance: Improving Quality and Research Practice through Ethics Review
Prof. Bruno Kubata, Co-ordinator of Research for Health & Pharmaceutical Innovation, AU-NEPAD & Member R4HA Team, COHRED
Boitumelo Mokgatla-Moipolai, COHRED
AMFm Capacity Strengthening [PDF]
Dr John Amuasi, Komfo Anokye Teaching Hospital (KATH), Ghana
Data Management Centre for LEAP Studies [PDF]
Raymond Omollo, Head Data Centre and Statistician, DNDi Africa
Beyond Clinical Trials: Training of Nurses to Roll Out NECT for Sleeping Sickness While Reinforcing Capacities in the Health System
Dr Jose Ramon Franco Minguell, Medical Officer, Human African Trypanosomiasis Programme, NTD Department, WHO
Patrice Kabangu Mundidimbi, Supervisor, East Kasaï Provincial Coordination Human African Trypanosomiasis National Control Programme, Ministry of Health, DRC
An Integrated Approach to Building Health Research Capacity
Dr Sam Kinyanjui, Head of Training KEMRI-Wellcome Trust
TDR Career Development Fellowship Programme Building Capacity that Lasts for Product Development and Registration
Dr Pascal Launois, Scientist, TDR
Dr Wilfried Mutombo, Human African Trypanosomiasis National Control Programme, Ministry of Health, DRC
5 June, 2013
5 JUNE CONFERENCE SPEAKERS PROGRAMME [PDF]
| A Decade of Innovative Partnerships in Africa for Excellence in Neglected Disease Research |
art II: Towards Standards for Harmonization
From Clinical Trials to widespread Access: Implementation of NECT Treatment / Human African Trypanosomiasis Platform
Dr Augustin Kadima Ebeja, Coordinator of the HAT Platform
Sharing of Expertise and Capacity Strengthening to Deliver a New Firstline Treatment for Kala Azar in East Africa / LEAP Platform
Dr Ahmed Musa Mudawi, Institute of Endemic Diseases, University of Khartoum, Sudan
Building a Global Partnership to Bring a New Vaccine to Patients: MenAfriVac, PATH-WHO
Dr Mamoudou Djingarey, MVP focal point and coordinator for vaccine introduction, Meningitis Vaccine Project (MVP) partnership between WHO and PATH
Risk Management Plan for ACT: The Case of ASAQ for Malaria
Dr François Bompart, Vice President, Deputy Head & Medical Director, Access to Medicines Sanofi
African Network for Drugs and Diagnostics Innovation (ANDI) – Building a Network of Excellence for health innovation in Africa
Dr Solomon Nwaka, Acting Director, African Network for Drugs and Diagnostics Innovation ANDI)
Reflections on a Decade of Innovation in Africa |
Creating and Sustaining an Enabling R&D Environment in Africa
Dr Charles Mgone, Executive Director, EDCTP
Where do We Stand with Drug Development for Neglected Diseases? Lessons Learned from DNDi’s Decade of R&D Followed by patient testimonial – A Life Saved by NECT: Yvette’s Story of Sleeping Sickness [VIDEO] Dr Bernard Pécoul, Executive Director, Drugs for Neglected Diseases initiative
Strategies for Neglected Diseases: What Roadblocks Need to be Overcome to Deliver the Right Tools for Elimination? |
Keynote address: Control and Elimination of NTDs: The Need for Broad-Based Support on Multiple Fronts [VIDEO] Dr Margaret Chan, Director, WHOvia video
Introductory Remarks: WHO NTD Roadmap Elimination Goals for Sleeping Sickness
Dr Pere Simarro, Medical Officer in charge of the WHO human African trypanosomiasis programme, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, World Health Organization
Global Challenges for Elimination of Neglected Diseases |
Elimination of HIV: Why We are Not Reaching the Mark for Children
Dr Tom Ellman, Director of MSF SAMU, South Africa Medical Unit South Africa.
Improving and Maintaining Clinical Research Capacity in Remote Settings: Timely Delivery of Health Tools
Dr Wilfred Mbacham, Associate Professor, Biotechnology Centre, Cameroon
Regional Centres of Regulatory Excellence (RCOREs) in Africa
Dr Margareth Ndomondo-Sigonda, Medicines Regulatory Harmonization (AMRH) Programme Coordinator, NEPAD Agency
